Live from the NIH registry
Studies recruiting near Santa Maria right now
Top 25 of 94 recruiting studies, sorted by proximity — each links to its official registry page
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Fallopian Tube Endometrioid Adenocarcinoma, Fallopian Tube High Grade Serous Adenocarcinoma
Phase 3
Interventional 880 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: NRG Oncology
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
Breast Cancer
Phase 3
Interventional 400 participants sought
Sansum Clinic — Solvang, California (29.1 mi)
· Sponsor: Pfizer
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
Non-alcoholic Fatty Liver Disease
Phase 3
Interventional 1,250 participants sought
GSK Investigational Site — Santa Maria, California (1.4 mi)
· Sponsor: GlaxoSmithKline
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Non-small Cell Carcinoma, Non-Small Cell Lung Cancer Metastatic
Phase 3
Interventional 680 participants sought
UCLA Hematology/Oncology - San Luis Obispo — San Luis Obispo, California (27.1 mi)
· Sponsor: Pfizer
Lenalidomide, and Dexamethasone With or Without Daratumumab in Treating Patients With High-Risk Smoldering Myeloma
Smoldering Plasma Cell Myeloma
Phase 3
Interventional 288 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: ECOG-ACRIN Cancer Research Group
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma
Phase 3
Interventional 1,295 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
PCR Oncology — Arroyo Grande, California (15.3 mi)
· Sponsor: SWOG Cancer Research Network
Adherence to Different Exercise Interventions
Exercise Adherence
N/A
Interventional 60 participants sought
California Polytechnic State University — San Luis Obispo, California (27.1 mi)
· Sponsor: California Polytechnic State University-San Luis Obispo
Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Cancer
Resectable Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8
Phase 3
Interventional 1,100 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Phase 2 Study to Evaluate Povetacicept in Adults With Generalized Myasthenia Gravis
Myasthenia Gravis, Generalized
Phase 2
Interventional 30 participants sought
Tri Valley Neurology Medical Associates Inc. — Mission Hills, California (17.1 mi)
· Sponsor: Vertex Pharmaceuticals Incorporated
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Obesity, Heart Failure
Phase 3
Interventional 5,610 participants sought
Fomat Medical Research — Santa Maria, California (1.4 mi)
· Sponsor: Novo Nordisk A/S
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8
Phase 2
Interventional 44 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 2,400 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Phase 3
Interventional 830 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Canadian Cancer Trials Group
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8
Phase 3
Interventional 1,524 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Alliance for Clinical Trials in Oncology
A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2
Urothelial Carcinoma
Phase 2
Interventional 372 participants sought
UCLA Hematology/Oncology - San Luis Obispo — San Luis Obispo, California (27.1 mi)
· Sponsor: Seagen, a wholly owned subsidiary of Pfizer
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
Metabolic Dysfunction-Associated Steatohepatitis, Non-alcoholic Fatty Liver Disease
Phase 2
Interventional 42 participants sought
GSK Investigational Site — Santa Maria, California (1.4 mi)
· Sponsor: GlaxoSmithKline
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
Plasma Cell Myeloma
Phase 3
Interventional 510 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: SWOG Cancer Research Network
Neoadjuvant Chemotherapy, Excision And Observation vs Chemoradiotherapy For Rectal Cancer
Rectal Cancer
Phase 3
Interventional 250 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: Canadian Cancer Trials Group
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
N/A
Observational 5,000 participants sought
PCR Oncology — Arroyo Grande, California (15.3 mi)
· Sponsor: National Cancer Institute LAO
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
Prostate Cancer
Phase 3
Interventional 700 participants sought
Research Site — San Luis Obispo, California (27.1 mi)
· Sponsor: AstraZeneca
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy
Diabetic Retinopathy
Phase 2
Interventional 175 participants sought
California Retina Consultants-Santa Maria-65510 — Santa Maria, California (1.4 mi)
· Sponsor: Boehringer Ingelheim
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Multiple conditions
Phase 2
Interventional 314 participants sought
Mission Hope Medical Oncology - Santa Maria — Santa Maria, California (1.4 mi)
· Sponsor: National Cancer Institute (NCI)
Phase 2 Study of Kylo-11 in ASCVD Patients With Elevated Lp(a)
Lipoprotein Disorder
Phase 2
Interventional 204 participants sought
FOMAT - Comprehensive Cardiovascular Care-Santa Maria California — Santa Maria, California (1.4 mi)
· Sponsor: Kylonova (Xiamen) Biopharma co., LTD.
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Recurrent B Acute Lymphoblastic Leukemia
Phase 2
Interventional 84 participants sought
PCR Oncology — Arroyo Grande, California (15.3 mi)
· Sponsor: National Cancer Institute (NCI)